Navigation Links
VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
Date:1/30/2013

ROCHESTER, N.Y., Jan. 30, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ:  VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Tuesday, February 19, 2013 it will release its fourth quarter and full year 2012 financial results. VirtualScopics' President and Chief Executive Officer, Jeff Markin , and Chief Business and Financial Officer, Molly Henderson , will host a conference call that morning at 11:00 a.m. ET to provide a business update and discuss the company's results for the quarter and year ended December 31, 2012.

Interested participants should call 877-407-8035 when calling within the United States or
+1 201 689 8035 when calling internationally.  This call can also be accessed at www.virtualscopics.com and will be available for 30 days after the call.

About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development.  VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.  In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.  For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. VirtualScopics Schedules Second Quarter 2012 Earnings Announcement
2. VirtualScopics Reports 2nd Quarter 2012 Results
3. VirtualScopics Announces Receipt of Notice from Nasdaq
4. VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
5. VirtualScopics Receives Issuance of Influential Patent in Canada
6. VirtualScopics Reports 3rd Quarter 2012 Results
7. Thoratec Schedules First Quarter Conference Call, Webcast
8. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
9. Heartware Schedules First Quarter Conference Call And Webcast
10. Ampio Pharmaceuticals Schedules 2012 Update Webcast
11. China Botanic Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between dropping ... health was forgotten. But Audicus , a next-generation ... better this new year. Hearing loss is ... aging population, though it is often unaddressed. Forty-eight million ... has a hearing aid, mainly due to price. Hearing ...
(Date:12/19/2014)... SAN DIEGO , Dec. 18, 2014  RESMED INC. ... report its second quarter of fiscal year 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:12/19/2014)... development with the growth pace keeping at 20%-30% in last ... size of China separating membrane products ... 16.3%. It is projected that China ... 20% in the upcoming years and that the figure by ... integrated membrane industrial system has taken shape in ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2ResMed To Announce Second Quarter 2015 Results 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... , , , , , , , , ... PARIS and LAUSANNE, Switzerland , February 4 ... and Debiopharm Group (Debiopharm), a Swiss-based global,biopharmaceutical group of companies ... unmet medical needs, announce the launch by,Ipsen in France ...
... , , ST. LOUIS , Feb. ... that its Board of Directors declared a quarterly dividend of ... to all shareholders of record on February 15, ... and equipment used by dentists, dental hygienists, dental assistants, and ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Young Innovations, Inc. Board of Directors Declares Quarterly Dividend 2
(Date:12/20/2014)... NY (PRWEB) December 20, 2014 ... allege a metal-on-metal version of the artificial hip ... in state and federal courts, Bernstein Liebhard LLP ... Jersey’ Bergen County Superior Court on December 2nd, ... to begin deposition of plaintiffs on November 19, ...
(Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
(Date:12/20/2014)... Developers of FCPX 3rd ... plugin for Final Cut Pro X entitled TranSlice Volume ... allows users to create hand drawn text animations without ... CEO of Pixel Film Studios. “TranSlice Volume 5 was ... an easy to use interface.” , TranSlice Volume 5 ...
(Date:12/19/2014)... Today, Balfleet.com , a leading ... its formal dress promotion. All the old and new ... off. , Balfleet.com is well-known for its high quality ... dresses, cocktail dresses and more. Its formal dresses are ... and they can create an elegant look when paired ...
(Date:12/19/2014)... Anaheim, CA (PRWEB) December 19, 2014 ... not-for-profit corporation dedicated to developing educational events, tools ... and Rouxbe Cooking School , the world’s ... develop the prescription every human being needs: Culinary ... and plant-based cooking course, Culinary Rx, scheduled for ...
Breaking Medicine News(10 mins):Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4
... , DURHAM, N.C., Oct. 19 Oxygen Biotherapeutics, Inc. (OTC ... reverse stock split. The vote was part of a general ... management,s nominees to the company board of directors. , At ... for the formal launch of the company,s Dermacyte(TM) Oxygen Concentrate ...
... blocked protects tissue, animal study finds, , MONDAY, Oct. ... shown in animal studies that providing supplemental oxygen during ... it,s not a simple matter. Success in preventing brain ... percent oxygen is given. , "The use of ...
... or suppliers in states that permit use of the drug ... has decided it will no longer prosecute medical marijuana users ... allow use of the drug for medicinal purposes. , The ... Department memo to federal prosecutors on Monday, are designed to ...
... Va.Seven medical imaging groups wrote a joint letter to ... formally request coverage of two fluorodeoxyglucose (FDG) positron emission ... treatment evaluation. Currently, CMS covers only one FDG-PET study ... contrary to good clinical practice under certain circumstances. ...
... dextrose right after surgery quells upset stomach, researchers say ... suggests that patients need not fear post-operative nausea and ... of glucose. , "As one of the most ... the main causes of decreased patient satisfaction following surgery," ...
... At the 2009 Fryeburg Fair, concluded on October ... Best Educational Display. Fryeburg Fair President Roy Andrews, along ... at the fairgrounds. , The award recognizes Poland Spring ... Natural Resources Pavilion. According to Poland Spring Natural Resource ...
Cached Medicine News:Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 2Health News:Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split 3Health News:Timing of Oxygen After a Stroke May Matter 2Health News:U.S. Relaxes Opposition to Medical Marijuana 2Health News:U.S. Relaxes Opposition to Medical Marijuana 3Health News:1 scan per patient is not always enough 2Health News:Easy Way to Prevent Post-Op Nausea? 2Health News:Fryeburg Fair Awards Poland Spring Team 'Best Educational Display' 2
With this more compact transducer face, this is the transducer of choice for obstetric imaging in areas with a small acoustic window....
... convex array is designed with the smaller ... with this multi-frequency transducer is ideal for ... of quick and accurate diagnoses. A choice ... need, and allows you to obtain high ...
... new XL3000 by PerkinElmer,is a ... latest in,Cermax Xenon technology.,Cermax Xenon ... technology,for integration into endoscopy,equipment and ... accurate color illumination.,It provides many ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
Medicine Products: